Clinical Trials in Belgium / NCT06780514
Recruiting
Not applicable
Cardiopulmonary Exercise Testing in Girls (8-18y) with Turner Sydrome.
NCT06780514 · tracked via the Priya Life Science Belgium tracker
Condition(s) studied
Turner Syndrome
Investigational drug(s) / intervention(s)
Cardiopulmonary exercise test
Cardiopulmonary exercise test: To our knowledge, this is the first study to perform CPET's in Turner Girls aged \<18 years
Study summary
The goal of this clinical trial is to have a beter insight in the exercise tolerance in girls with Turner Syndrome aged 8-18 years . The main question it aims to answer is:
Is there a difference in VO2 max comparing Turner syndrome girls with standard values? How do cardiovascular parameters change during exercise (heart rate, bloodpressure, ...)
Participants will perform a cyclo-ergometry in a standardised way.
Eligibility
Inclusion Criteria:
* Turner syndrome girls aged 8-18 years old
Exclusion Criteria:
* Severe mental impairement making it impossible to perform an exercise test
Primary outcome measure(s)
- VO2 max — Whitin a week after the CPET
VO2 max is the maximum volume (V) of oxygen (O2) your body can process during exercise
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ghent University Hospital | Ghent | Belgium | Recruiting |
More University Hospital, Ghent trials in Belgium
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06780514 on ClinicalTrials.gov ↗ ← All trials in Belgium